Aoxing Pharmaceutical Company Inc
(AMEX: AXN)
| 2012 | 2011 | 2010 | 2009 | 2008 | |
| Period End Date | 06/30/2012 | 06/30/2011 | 06/30/2010 | 06/30/2009 | 06/30/2008 |
| Period Length | 12 Months | 12 Months | 12 Months | 12 Months | 12 Months |
| Stmt Source | 10-K | 10-K/A | 10-K | 10-K | 10KSB |
| Stmt Source Date | 10/15/2012 | 09/28/2012 | 10/04/2010 | 10/04/2010 | 10/14/2008 |
| Stmt Update Type | Updated | Updated | Updated | Reclassified | Updated |
| Net Income/Starting Line | -15.82 | -7.41 | -0.83 | -2.45 | 3.65 |
| Depreciation/Depletion | 1.08 | 1.15 | 1.12 | 1.02 | 0.73 |
| Amortization | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Deferred Taxes | 0.0 | 3.39 | -0.06 | -3.33 | 0.0 |
Non-Cash Items
|
14.09 | -0.1 | -3.96 | 2.69 | -5.93 |
| Accounting Change | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Unusual Items | 13.4 | 0.04 | -3.61 | 0.88 | 0.0 |
| Equity in Net Earnings (Loss) | 0.13 | 0.0 | 0.0 | 0.0 | 0.0 |
| Other Non Cash Items | 0.56 | -0.14 | -0.35 | 1.81 | -5.93 |
|
Changes in Working Capital
|
-0.68 | 0.29 | -0.25 | 1.43 | 0.57 |
| Prepaid Expenses | -0.07 | -0.06 | -0.33 | -0.27 | 0.08 |
| Accrued Expenses | 0.4 | 1.27 | 1.84 | 2.78 | -0.44 |
| Accounts Receivable | -0.76 | -1.11 | -0.88 | 0.03 | -0.53 |
| Inventories | -0.28 | 0.12 | -1.03 | 0.14 | -0.17 |
| Payable/Accrued | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Accounts Payable | 0.04 | 0.07 | 0.14 | -1.24 | 1.63 |
| Cash from Operating Activities | -1.33 | -2.67 | -3.98 | -0.64 | -0.98 |
|
Capital Expenditures
|
-0.75 | -1.37 | -2.0 | -2.23 | -1.48 |
| Purchase/Acquisition of Intangibles | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Purchase of Fixed Assets | -0.75 | -1.37 | -2.0 | -2.23 | -1.48 |
|
Other Investing Cash Flow Items, Total
|
0.0 | 0.66 | 0.21 | 0.0 | -15.65 |
| Intangibles, Net | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Acquisition of Business | 0.0 | 0.0 | 0.0 | 0.0 | -12.23 |
| Sale of Fixed Assets | 0.0 | 0.01 | 0.95 | 0.0 | 0.0 |
| Other Investing Cash Flow | 0.0 | 0.65 | -0.75 | 0.0 | -3.42 |
| Cash from Investing Activities | -0.75 | -0.72 | -1.79 | -2.23 | -17.14 |
|
Financing Cash Flow Items
|
0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Other Financing CashFlow | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Total Cash Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Issuance (Retirement) of Stock, Net | 0.0 | 0.0 | 5.0 | 0.0 | 17.1 |
| Issuance (Retirement) of Debt, Net | 2.82 | 1.98 | 3.42 | 2.75 | 1.32 |
| Cash from Financing Activities | 2.82 | 1.98 | 8.42 | 2.75 | 18.42 |
| Foreign Exchange Effects | 0.17 | 0.19 | 0.07 | -0.18 | -0.25 |
| Net Change in Cash | 0.91 | -1.21 | 2.71 | -0.3 | 0.05 |
| Net Cash - Beginning Balance | 2.77 | 3.99 | 1.27 | 1.57 | 1.51 |
| Net Cash - Ending Balance | 3.68 | 2.77 | 3.99 | 1.27 | 1.57 |
Copyright © 2013 Microsoft. All rights reserved.
Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.
Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations data provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.
Japanese stock price data provided by Nomura Research Institute Ltd.; quotes delayed 20 minutes. Canadian fund data provided by CANNEX Financial Exchanges Ltd.